InSet Technologies (Mt. Olive, NJ) an early-stage company developing implantable pumps delivering targeted medications directly to the spinal cord (intrathecal space) to achieve potentially improved functional relief with a dramatic reduction in the side effects from high doses of drugs for chronic pain, closed a $25M Series B financing. Participants include Clarus Ventures and FatBoy Capital.